2019 American Transplant Congress
Low-Dose Valacyclovir Prophylaxis for Cytomegalovirus Infection in Renal Transplant Recipients with Intermediate Risk
*Purpose: According to recent guidelines ganciclovir or valganciclovir chemoprophylaxis is recommended for all kidney transplantation (KT) recipients (except for D-/R- serology) for preventing cytomegalovirus (CMV)…2019 American Transplant Congress
Kidney Biopsies In Hiv-negative To Hiv-positive Kidney Transplants – An Institutional Experience
*Purpose: Increased life expectancy in HIV+ patients has resulted in an increase in CKD leading to ESRD; and therefore renal transplantation in these individuals is…2019 American Transplant Congress
Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living Donor Kidney Transplantation
1University of Alabama at Birmingham, Birmingham, AL, 2Tuskegee University, Tuskegee, AL
*Purpose: No living donation program has addressed transplant candidate factors by separating the advocacy role from the candidates while simultaneously addressing potential living donor concerns…2019 American Transplant Congress
Arterial Blood Pressure Circadian Rhythm in Renal Transplant Recipients
*Purpose: Approximately 80% kidney transplant (KT) recipients have high blood pressure, compromising graft survival and increasing cardiovascular risk. In the pre-transplant stage, alterations in blood…2019 American Transplant Congress
Surgical Outcome and Analysis of Risk of Complications in Kidney Donors Receiving Laparoscopic Live Donor Nephrectomy
Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
*Purpose: Laparoscopic live donor nephrectomy has adopted for more than 20 years. But the operative procedure is still technically demanding, and allows almost no margin…2019 American Transplant Congress
Guideline Adherence for Secondary Prevention of Stroke and Atherosclerotic Cardiovascular Disease among Liver Transplant Recipients
*Purpose: Data about provider adherence to clinical practice guidelines for secondary prevention of stroke and atherosclerotic cardiovascular disease (ASCVD) among liver transplant recipients (LTRs), which…2019 American Transplant Congress
Incidence and Risks for Non-alcoholic Fatty Liver Disease and Steatohepatitis Post Liver Transplant: Systematic Reveiw and Meta-Analysis
1Beaumont Hospital, Ann Arbor, MI, 2University of Michigan, Ann Arbor, MI
*Purpose: Recurrent and denovo non-alcoholic fatty liver (NAFLD) and non-alcoholic steatohepatitis (NASH) are important post-liver transplant (LT) outcomes given risk to graft viability. The true…2019 American Transplant Congress
Clinical Outcomes of Patients with Portal Vein Tumor Thrombi after Living Donor Liver Transplantation
Surgery, Seoul St. Mary's Hospital, Catholic University of Korea, Seoul, Korea, Republic of
*Purpose: Patient selection criteria for living donor liver transplantation(LDLT) with hepatocellular carcinoma are generally wider than those for deceased donor liver transplantation. It is widely…2019 American Transplant Congress
Correlations between Preoperative Hepatic Venous Pressure Gradient and Graft Hemodynamics after Reperfusion in Living Donor Liver Transplantation
*Purpose: Hepatic venous pressure gradient (HVPG) is known to correlate with severity of portal hypertension in patients with liver cirrhosis. We retrospectively investigated the clinical…2019 American Transplant Congress
Exendin-4 for Donor Treatment in a Brain-Death Model of Kidney Transplantation
*Purpose: Renal grafts from brain death donors associated with poorer graft outcomes after kidney transplantation, hemodynamic and inflammatory mechanisms can account for brain death induce…
- « Previous Page
- 1
- …
- 100
- 101
- 102
- 103
- 104
- …
- 214
- Next Page »